Advanced Search: Combination

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.



Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors


A Phase 1/2 First-in-human Study of BMS-986288 Alone and in Combination with Nivolumab in Advanced Malignant Tumors


A Phase 1 Dose Escalation Trial of SYN125 Single Agent and in Combination with Fixed Dose SYN004 in Patients with Advanced Colorectal and Head and Neck Cancer


An Open-label Phase 1b/2a Study of NT-I7 (Hyleukin-7) in Combination with Pembrolizumab in Subjects with Relapsed/Refractory Advanced Solid Tumors


A Phase 1/2a, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-3312 in Combination with Pembrolizumab or Binimetinib in Adult Patients with Advanced Solid Tumors


A Phase 1b, Open-label, Dose-escalation Trial Of The Safety Of And Antigen-specific Immune Responses Elicited By Vb.10 Neo In Combination With Atezolizumab In Subjects With Locally Advanced And Metastatic Tumors